Dellon Evan S, Furuta Glenn T, Tomeo Nick, Karavanov Anya, Smernoff Zoe, Harrington Joy, Aceves Seema S
Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Division of Gastroenterology and Hepatology, Department of Medicine, Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Gastro Hep Adv. 2024 Dec 27;4(4):100604. doi: 10.1016/j.gastha.2024.100604. eCollection 2025.
A new application (app) allows the Index of Severity for EoE (I-SEE) to be used at the point of care. We aimed to perform usability testing of the I-SEE mobile app and identify areas for improvement.
We recruited 60 practitioners (20 adult and 20 pediatric gastroenterologists; 20 allergists) to use I-SEE on ≥5 EoE patients seen in clinic and undergo interviews by trained qualitative researchers. The interview guide focused on overall user experience, user satisfaction, and desired improvements. It also explored potential perceived barriers to using the app and I-SEE.
Though I-SEE was new to most providers, they found it took only a few minutes to calculate the score. All interviewees either "agreed" (5%) or "strongly agreed" (95%) with the statement, "The app was easy to navigate," and almost all (95%) either "agreed" (42%) or "strongly agreed" (53%) with "The app's features and functionalities were intuitive and easy to understand". The large majority (85%) reported satisfaction with the app. Responses were similar for allergists, and adult and pediatric gastroenterologists. Areas of suggested improvement included updating design features, incorporation into electronic medical records, addressing if scoring for children and adults should be different, and clarifying clinical implications of I-SEE for management.
The I-SEE app was user friendly and able to be completed rapidly in clinical practice. Interviewee feedback led to app updates to improve visualization and use. In the future, scoring for children should be confirmed and I-SEE should be validated by linking severity to treatment and monitoring recommendations.
一款新应用程序(app)可让医疗现场使用嗜酸性食管炎严重程度指数(I-SEE)。我们旨在对I-SEE移动应用程序进行可用性测试,并确定改进的方面。
我们招募了60名从业者(20名成人及20名儿科胃肠病学家;20名过敏症专科医生),让他们在≥5例临床所见的嗜酸性食管炎患者中使用I-SEE,并接受经过培训的定性研究人员的访谈。访谈指南聚焦于总体用户体验、用户满意度及期望的改进。它还探讨了使用该应用程序及I-SEE可能存在的感知障碍。
尽管大多数提供者对I-SEE并不熟悉,但他们发现计算分数只需几分钟。对于“该应用程序易于操作”这一表述,所有受访者要么“同意”(5%),要么“强烈同意”(95%);对于“该应用程序的功能直观且易于理解”,几乎所有受访者(95%)要么“同意”(42%),要么“强烈同意”(53%)。绝大多数(85%)报告对该应用程序满意。过敏症专科医生、成人及儿科胃肠病学家的反馈相似。建议改进的方面包括更新设计功能、纳入电子病历、解决儿童和成人评分是否应有所不同的问题,以及阐明I-SEE对管理的临床意义。
I-SEE应用程序用户友好,在临床实践中能够快速完成。受访者的反馈促使对应用程序进行更新以改善可视化和使用。未来,应确定儿童评分,并通过将严重程度与治疗及监测建议相联系来验证I-SEE。